despite being a very common disease, all patients with diabetes has a unique method of treatment. In rare cases, if the condition is not treated, it can lead to a large number of complicated situations. Common treatments include maintaining a healthy diet and eating habits. The latest development in the field of diabetes treatment is to introduce the first and only weekly medication called Trulicity , which becomes a part of a rare kind of injections that allow even more users to manage the blood sugar levels of type 2 diabetes
most of the human population suffering from diabetes exhibit the variety of type-2. This causes high blood sugar levels which in turn leads to health problems such as vision problems, heart disease and nerve and kidney damage.
Trulicity (common name Dulaglutide) is a type of medicine called glucagon-like-1 (GLP-1) receptor agonist peptide. Initial tests were conducted by the FDA (US Food and Drug), which brings together about 3500 subjects with type 2 diabetes were carried out individual tests as well as combinational using other medicines diabetes. A notable improvement in blood sugar levels in the long term was observed in patients who received weekly doses of medication.
Common side effects of using this drug include vomiting, nausea, diarrhea, decreased appetite and abdominal pain. Trucility is not recommended for patients with a family history of any form of thyroid cancer or for patients who have tumors in different glands in the body. It is not prescribed for people with type 1 diabetes or even as the first treatment for patients with type 2